Joachim J, François N, Piccerelle P, Kister J, Reynier J-P, Humbert P, Aubin F
Service central de la pharmacie et du médicament, Laboratoire de contrôle de la qualité, Hôpital de la Conception, Marseille (13).
Presse Med. 2005 Dec 17;34(22 Pt 1):1727-36. doi: 10.1016/s0755-4982(05)84261-7.
Psoriasis is a common dermatosis that affects 3-5% of the European population. Current treatments offer considerable clinical benefits, but their use is limited due to tolerance problems. Recent years have seen the development of new treatments, used separately or in combination to improve the chronic lesions caused by this disease. T cells play an important role in the pathogenesis of psoriasis. Various techniques target the T cells and the immunological mechanisms involved in their activation. In 2005, treatment of psoriasis is directed essentially towards immunological pathways.
银屑病是一种常见的皮肤病，影响着3%至5%的欧洲人口。目前的治疗方法带来了显著的临床益处，但由于耐受性问题，其应用受到限制。近年来出现了新的治疗方法，单独使用或联合使用以改善由该疾病引起的慢性皮损。T细胞在银屑病的发病机制中起重要作用。各种技术针对T细胞及其激活所涉及的免疫机制。2005年，银屑病的治疗主要针对免疫途径。
